ERBB2 and breast adenocarcinoma: In silico analysis further identified Erbb2 as a differentially up-regulated (2.1-fold, p<0.05 at day 21) nexus gene of “mammary adenocarcinoma” and “mammary development” at day 21 and day 28 (Figure 4).